Predict your next investment

HEALTHCARE | Medical Facilities & Services / Medical Laboratories & Research

See what CB Insights has to offer

About Cutaneous Biology Research Center

Cutaneous Biology Research Center (CBRC) promotes biological discovery and hypothesis testing, particularly as related to translational questions in dermatology and skin health. The topics investigated at the CBRC span research areas, including molecular/cellular biology of skin, stem cells, epigenetics, immunobiology, chemical biology/screening, topical drug delivery, itch, UV protection, metabolism, cancer biology, inflammation, pigmentation, hair follicle biology, and laser application.

Cutaneous Biology Research Center Headquarter Location

Massachusetts,

United States

Latest Cutaneous Biology Research Center News

Shiseido Marks the 30th Anniversary of Joint Research in Dermatology

Sep 18, 2019

Shiseido Company, Limited (“Shiseido”) has agreed on Tuesday, September 17, 2019 to extend for a further six years its research alliance with the dermatological laboratory CBRC (Cutaneous Biology Research Center), established by Harvard Medical School Dermatology Research Labs, and Massachusetts General Hospital in Boston, Massachusetts, USA. This new agreement will be effective July 2021 through June 2027. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190917006201/en/ Shiseido’s President and CEO, M. Uotani, Executive Vice President, Y. Shimatani, CBRC Director, Dr. D.E.Fisher and President, MGH Dr. P. Slavin (Photo: Business Wire) The CBRC was founded in 1989, and is known as a world-class laboratory in the field of dermatology. Shiseido has been collaborating for 30 years with the CBRC as a pioneer of open innovation pursuing unprecedented research collaboration with external organizations both nationally and internationally. Many of the cutting-edge research results are utilized in our product research and development. Going forward, to achieve our corporate mission, “BEAUTY INNOVATIONS FOR A BETTER WORLD,” Shiseido will continue joint research with the CBRC and create cutting-edge value through research in dermatology including ultraviolet rays and aging, as well as development of innovative cosmetic products. Furthermore, in addition to research and development, we will also provide consumers with information to maintain healthy skin, such as basic knowledge on UV rays and the impact of photoaging, etc. through seminars and symposiums. To celebrate the 30th anniversary of the CBRC and new six-year extension of the alliance, three representatives—Shiseido’s President and CEO Masahiko Uotani, Executive Vice President Yoichi Shimatani, and CBRC Director David E. Fisher, MD, PhD—gave comments as follows: Shiseido’s President and CEO, Masahiko Uotani: “In our quest to remain vital for the next 100 years and beyond, this year, we at Shiseido created a new corporate mission “BEAUTY INNOVATIONS FOR A BETTER WORLD.” Ongoing efforts to foster innovation is our responsibility and mission to make this world better through the power of beauty. The CBRC is an indispensable and important partner for Shiseido to create unprecedented, first-of-its-kind value and change the lives of people around the world. Let us cling together for the future and challenge for the innovation that surpasses society's expectations.” Executive Vice President, Yoichi Shimatani: “It has been 30 years since we began our partnership with the CBRC. We have delivered many outstanding research achievements, more than we had initially imagined, realizing ideal collaboration between laboratories in academia and a company. We will continue to create innovation with the CBRC, a state-of-the-art laboratory that symbolizes our open innovation activities.” CBRC Director, David E. Fisher: “The Shiseido-CBRC relationship is a source of immense pride to Dermatology at Mass General Hospital/Harvard Medical School. Close collaboration at the cutting edge of science is the shared mission, and numerous significant discoveries continue to be made through common efforts. We are proud to celebrate 30 years of important discoveries by our scientists working together, and look forward to continued progress in optimizing all aspects of skin health and wellbeing.” About CBRC The CBRC is a general research institute for advanced research and development in the field of dermatology established by Harvard Medical School and Massachusetts General Hospital with support from Shiseido in 1989. We started collaborative research 30 years ago and since then we have achieved many remarkable research results in skin and hair science. Many researchers have also been dispatched from Shiseido, contributing to the cultivation of global research talent. [Reference] Discovered the mechanism of two genes TSC-22 and Smad2 involved in epilation. 2005 "Ultraviolet B-induced skin angiogenesis is associated with a switch in the balance of vascular endothelial growth factor and thrombospondin-1 expression" Elucidated that the induction of capillaries beneath the epidermis due to UV irradiation causes wrinkles. 2007 "Dedicated epithelial recipient cells determine pigmentation patterns" Newly found that pigment recipient cells send a signal to pigment cells to determine the pigmentation pattern. This research paper was published in the world-renowned academic journal Cell in 2007. 2009 "Hepatocyte growth factor promotes lymphatic vessel formation and function" "A Novel Mechanism of Cutaneous Photo-Aging Mediated by the Impairment of Lymphatic Function and the Protective Role of a Lymphatic-promoting Compound” Discovered that UV-exposed skin deteriorates the function of lymphatic vessels, leading to the creation of wrinkles. Furthermore, developed the drug that suppresses the phenomenon. 2010 “Reduction of oxidative stress in living body by promoting expression of redox-related factors” Discovered that kaempferol, a kind of polyphenol, and ginkgo biloba, which contains kaempferol, significantly suppress the level of cell damage caused by UV rays. Shiseido and CBRC jointly own the patents (joint applications). 2016 "Ex-vivo demonstration of the disruption of skin homeostasis and the role of extracellular ATP in the reaction" "Ex-vivo analysis of localized response to environmental stress in human skin" Discovered that heparanase, one of the factors that promote basement membrane degradation, increases in the epidermis due to external environmental stress such as dryness. * IFSCC (The International Federation of Societies of Cosmetic Chemists): An international organization dedicated to the development of highly functional and safe cosmetic technology through the world-wide cooperation of cosmetic societies. View source version on businesswire.com: https://www.businesswire.com/news/home/20190917006201/en/ Ms. June Sato

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.